Inozyme Pharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
TRECO DOUGLAS A director, officer: CEO
 Common Stock 7,523 $6.94 $52,210
Option
TRECO DOUGLAS A director, officer: CEO
 Restricted Stock Units 25,000 N/A N/A
Option
TRECO DOUGLAS A director, officer: CEO
 Common Stock 25,000 N/A N/A
Purchase
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. director
 Common Stock 119,048 $4.8 $571,430
Purchase
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. director
 Common Stock 714,285 $4.8 $3,428,568
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 119,048 $4.8 $571,430
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 714,285 $4.8 $3,428,568
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 228,702 $6.25 $1,429,388
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 219,230 $6.48 $1,420,610
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 344,592 $4.54 $1,563,758
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 156,766 $4.16 $652,303
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 51,074 $3.7 $188,718
Purchase
BJARKE HENRIC BJORN officer: SVP, COO
 Common Stock 21,500 $1.39 $29,885
Purchase
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. director
 Common Stock 1,070,000 $3.69 $3,948,300
Purchase
SUBRAMANIAN SANJAY officer: SVP, CFO
 Common Stock 27,100 $3.69 $99,999
Purchase
BOLTE AXEL director, officer: Chief Execut..
 Common Stock 67,750 $3.69 $249,998
Purchase
HOPFNER ROBERT LORNE director
 Common Stock 1,070,000 $3.69 $3,948,300
Purchase
BJARKE HENRIC BJORN officer: SVP, COO
 Common Stock 27,100 $3.69 $99,999
Purchase
LONGITUDE CAPITAL PARTNERS III, LLC 10 percent owner
 Common Stock 1,355,000 $3.69 $4,999,950
Option
BOLTE AXEL director, officer: Chief Execut..
 Common Stock 66,788 $0.98 $65,452
Sale
BOLTE AXEL director, officer: Chief Execut..
 Common Stock 66,788 $0.98 $65,452
Option
BOLTE AXEL director, officer: Chief Execut..
 Stock Option (right to buy) 66,788 $0.98 $65,452
Sale
NOVO HOLDINGS A/S 10 percent owner
 COMMON STOCK 375,000 $21 $7,875,000
Purchase
SOFINNOVA VENTURE PARTNERS X, L.P. 10 percent owner
 Common Stock 437,500 $16 $7,000,000
Purchase
HOPFNER ROBERT LORNE director, 10 percent owner
 Common Stock 187,500 $16 $3,000,000
Purchase
LONGITUDE CAPITAL PARTNERS III, LLC 10 percent owner
 Common Stock 625,000 $16 $10,000,000
Purchase
ROCK SPRINGS CAPITAL MANAGEMENT LP 10 percent owner
 Common Stock 600,000 $16 $9,600,000
Purchase
SANOFI 10 percent owner
 Common Stock (par value $0.0001) 81,250 $16 $1,300,000
Purchase
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. 10 percent owner
 Common Stock 187,500 $16 $3,000,000
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 600,000 $16 $9,600,000
Purchase
NEW ENTERPRISE ASSOCIATES 15, L.P. 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
BASKETT FOREST 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
FLORENCE ANTHONY A. JR. 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
MAKHZOUMI MOHAMAD 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
MAKOWER JOSHUA 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
SANDELL SCOTT D 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
SONSINI PETER W. 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
NOVO HOLDINGS A/S 10 percent owner
 COMMON STOCK 375,000 $16 $6,000,000
Purchase
ROCK SPRINGS CAPITAL MANAGEMENT LP 10 percent owner
 Common Stock 600,000 $16 $9,600,000

Showing 1 to 39 of 39 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: